Fisetin Inhibits Osteoclast Differentiation via Downregulation of p38 and c-Fos-NFATc1 Signaling Pathways

Fisetin Inhibits Osteoclast Differentiation via Downregulation of p38 and c-Fos-NFATc1 Signaling Pathways

The prevention or therapeutic treatment of loss of bone mass is an important means of improving the quality of life for patients with disorders related to osteoclast-mediated bone loss. Fisetin, a flavonoid dietary ingredient found in the smoke tree (Continus coggygria), exhibits various biological...

Full description

Bibliographic Details
Main Authors:	Sik-Won Choi, Young-Jin Son, Jung-Mi Yun, Seong Hwan Kim
Format:	Article
Language:	English
Published:	Hindawi Limited 2012-01-01
Series:	Evidence-Based Complementary and Alternative Medicine
Online Access:	http://dx.doi.org/10.1155/2012/810563

Similar Items

In vitro anti-osteoclastogenic activity of p38 inhibitor doramapimod via inhibiting migration of pre-osteoclasts and NFATc1 activity
by: Seong-Hee Moon, et al.
Published: (2015-11-01)

Inhibitory Effect of Purpurogallin on Osteoclast Differentiation in Vitro through the Downregulation of c-Fos and NFATc1
by: Kiryeong Kim, et al.
Published: (2018-02-01)

Anti-osteoclastogenic activity of praeruptorin A via inhibition of p38/Akt-c-Fos-NFATc1 signaling and PLCγ-independent Ca2+ oscillation.
by: Jeong-Tae Yeon, et al.
Published: (2014-01-01)

The Coumarin Derivative 5′-Hydroxy Auraptene Suppresses Osteoclast Differentiation via Inhibiting MAPK and c-Fos/NFATc1 Pathways
by: Basem M. Abdallah, et al.
Published: (2019-01-01)

Aqueous extract of Chrysanthemum morifolium Ramat. inhibits RANKL-induced osteoclast differentiation by suppressing the c-fos/NFATc1 pathway
by: Jang, H.-Y, et al.
Published: (2021)

Inhibition of RANKL-stimulated osteoclast differentiation by Schisandra chinensis through down-regulation of NFATc1 and c-fos expression
by: Eun-Jung Kim, et al.
Published: (2018-10-01)

The Effects of Aronia melanocarpa ‘Viking’ Extracts in Attenuating RANKL-Induced Osteoclastic Differentiation by Inhibiting ROS Generation and c-FOS/NFATc1 Signaling
by: Mithun Ghosh, et al.
Published: (2018-03-01)

Letrozole Suppresses the Fusion of Osteoclast Precursors through Inhibition of p38-Mediated DC-STAMP Pathway
by: Hyung Joon Kim, et al.
Published: (2020-11-01)

Fisetin Inhibits Hyperglycemia-Induced Proinflammatory Cytokine Production by Epigenetic Mechanisms
by: Hye Joo Kim, et al.
Published: (2012-01-01)

Betulin Suppresses Osteoclast Formation via Down-Regulating NFATc1
by: Kwang-Jin Kim, et al.
Published: (2018-06-01)

Norisoboldine suppresses osteoclast differentiation through preventing the accumulation of TRAF6-TAK1 complexes and activation of MAPKs/NF-κB/c-Fos/NFATc1 Pathways.
by: Zhi-Feng Wei, et al.
Published: (2013-01-01)

Erratum to: Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells
by: Jeong-Mi Kim, et al.
Published: (2017-04-01)

Arctigenin inhibits osteoclast differentiation and function by suppressing both calcineurin-dependent and osteoblastic cell-dependent NFATc1 pathways.
by: Teruhito Yamashita, et al.
Published: (2014-01-01)

Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis
by: Minsun Kim, et al.
Published: (2020-02-01)

The polyphenol fisetin protects bone by repressing NF-κB and MKP-1-dependent signaling pathways in osteoclasts.
by: Laurent Léotoing, et al.
Published: (2013-01-01)

Involvement of PU.1 in NFATc1 promoter function in osteoclast development
by: Kentaro Ishiyama, et al.
Published: (2015-07-01)

Antiresorptive Activity of Bacillus-Fermented Antler Extracts: Inhibition of Osteoclast Differentiation
by: Sik-Won Choi, et al.
Published: (2013-01-01)

Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation
by: Lili Wu, et al.
Published: (2019-12-01)

Do we use methylation of NFATC1 and FOS genes as a biomarker for postmenopausal osteoporosis?
by: Kalkan R, et al.
Published: (2021-03-01)

Regulatory mechanism of NFATc activation by p38 MAPK in T cells.
by: Chia-Cheng wu, et al.
Published: (2003)

6′-O-Galloylpaeoniflorin Attenuates Osteoclasto-genesis and Relieves Ovariectomy-Induced Osteoporosis by Inhibiting Reactive Oxygen Species and MAPKs/c-Fos/NFATc1 Signaling Pathway
by: Wenjie Liu, et al.
Published: (2021-04-01)

Bone marrow stromal cell proliferation in mice lacking NFATc1 in mature osteoclasts
by: Quang, Jonathan Q.
Published: (2015)

Necrostatin－7 suppresses RANK－NFATc1 signaling and attenuates macrophage to osteoclast differentiation
by: Fuji, Hiroaki
Published: (2019)

Phenotypic analysis of osteoclast lineage in c-fos mutant mice
by: Zhao, Yuming
Published: (2003)

MiR-30a Inhibits the Epithelial—Mesenchymal Transition of Podocytes through Downregulation of NFATc3
by: Rui Peng, et al.
Published: (2015-10-01)

Knockdown of Tcirg1 inhibits large-osteoclast generation by down-regulating NFATc1 and IP3R2 expression.
by: Dongyan Zhang, et al.
Published: (2020-01-01)

Agelasine D Suppresses RANKL-Induced Osteoclastogenesis via Down-Regulation of c-Fos, NFATc1 and NF-κB
by: Moo Rim Kang, et al.
Published: (2014-11-01)

Regulation of osteoblast and osteoclast differentiation by c-Fos and Msx transcription factors
by: Beedles, Karen Elizabeth
Published: (2002)

Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS Activity
by: Jianbo He, et al.
Published: (2021-09-01)

(+)-Vitisin A inhibits osteoclast differentiation by preventing TRAF6 ubiquitination and TRAF6-TAK1 formation to suppress NFATc1 activation.
by: Wen-Fei Chiou, et al.
Published: (2014-01-01)

The dataset of methylglyoxal activating p38 and p44/42 pathway in osteoclast
by: Kwan Ming Lee, et al.
Published: (2019-10-01)

TGF-β inducible early gene 1 regulates osteoclast differentiation and survival by mediating the NFATc1, AKT, and MEK/ERK signaling pathways.
by: Muzaffer Cicek, et al.
Published: (2011-03-01)

Diphlorethohydroxycarmalol from Ishige okamurae Suppresses Osteoclast Differentiation by Downregulating the NF-κB Signaling Pathway
by: Hye Jung Ihn, et al.
Published: (2017-12-01)

Protein phosphatase 1 regulatory subunit 18 suppresses the transcriptional activity of NFATc1 via regulation of c-fos
by: Kazuma Yasuda, et al.
Published: (2021-12-01)

Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c‐Fos/NFATc1 signaling pathway
by: Wenli Jiang, et al.
Published: (2020-11-01)

Signal transduction studies on single cell level: P38, but not NFATc2, is the main regulator of NFATc1/A expression in human Th cells
by: Baumgrass R, et al.
Published: (2009-02-01)

Rhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-κB/NFATc1 Signaling.
by: Mineko Tomomura, et al.
Published: (2015-01-01)

Pyrroloquinoline quinine inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos in mouse bone marrow cells and inhibits wear particle-induced osteolysis in mice.
by: Lingbo Kong, et al.
Published: (2013-01-01)

Pharmacological aspects of fisetin
by: Lucia Dwi Antika, et al.
Published: (2021-01-01)

New Perspectives for Fisetin
by: Grzegorz Grynkiewicz, et al.
Published: (2019-10-01)